ID

36032

Beschreibung

SMV + SOF With/Without RBV for IFN-II Patients With CHC; ODM derived from: https://clinicaltrials.gov/show/NCT02214420

Link

https://clinicaltrials.gov/show/NCT02214420

Stichworte

Versionen (1)
  1. 10.04.19 10.04.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

10. April 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis C NCT02214420

Englisch

Eligibility Hepatitis C NCT02214420

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. targeted at least 20% enrollment of patients with cirrhosis
Beschreibung

Liver Cirrhosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0023890
2. adults >/= age 18 years.
Beschreibung

Adult | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
3. active infection with hcv genotype 1
Beschreibung

Hepatitis C Genotype

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C1285573
4. must have health insurance that covers therapy with sof+rbv
Beschreibung

Health Insurance | sofosbuvir | Ribavirin

Datentyp

boolean

Alias
UMLS CUI [1]
C0021682
UMLS CUI [2]
C2976303
UMLS CUI [3]
C0035525
5. female patients of childbearing age must have a negative pregnancy test prior to initiating therapy, use at least two effective methods of contraception during treatment, and undergo monthly pregnancy tests.
Beschreibung

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods Quantity | Childbearing Potential Pregnancy Tests

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0032976
6. patients must be either ifn-ineligible due to psychiatric, autoimmune, neurological, or other causes that are confirmed appropriate by the pi; or,
Beschreibung

Patients Ineligible Interferon | Etiology Mental disorders | Etiology Autoimmune Diseases | Etiology Nervous system disorder

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1512714
UMLS CUI [1,3]
C3652465
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0004936
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C0004364
UMLS CUI [4,1]
C0015127
UMLS CUI [4,2]
C0027765
7. ifn-intolerant due to flu-like symptoms, psychiatric problems, cytopenia or other causes deemed appropriate by the pi.
Beschreibung

Intolerance to Interferon | Etiology Influenza-like symptoms | Etiology Psychiatric problem | Etiology Cytopenia

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C3652465
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0392171
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C1306597
UMLS CUI [4,1]
C0015127
UMLS CUI [4,2]
C0010828
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. presence of hiv co-infection
Beschreibung

HIV coinfection

Datentyp

boolean

Alias
UMLS CUI [1]
C4062778
2. presence of hcc
Beschreibung

Liver carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2239176
3. prior organ transplantation
Beschreibung

Organ Transplantation

Datentyp

boolean

Alias
UMLS CUI [1]
C0029216
4. any history of hepatic decompensation
Beschreibung

Hepatic decompensation

Datentyp

boolean

Alias
UMLS CUI [1]
C1394798
5. patients taking any of the following medications:
Beschreibung

Intake Pharmaceutical Preparations

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512806
UMLS CUI [1,2]
C0013227
anticonvulsants- carbamazepine, oxcarbazepine, phenobarbital, or phenytoin.
Beschreibung

Anticonvulsants | Carbamazepine | oxcarbazepine | Phenobarbital | Phenytoin

Datentyp

boolean

Alias
UMLS CUI [1]
C0003286
UMLS CUI [2]
C0006949
UMLS CUI [3]
C0069751
UMLS CUI [4]
C0031412
UMLS CUI [5]
C0031507
anti-infectives-erythromycin, clarithromycin, or telithromycin.
Beschreibung

Anti-Infective Agents | Erythromycin | Clarithromycin | telithromycin

Datentyp

boolean

Alias
UMLS CUI [1]
C0003204
UMLS CUI [2]
C0014806
UMLS CUI [3]
C0055856
UMLS CUI [4]
C0907410
antifungals- systemic itraconazole, ketoconazole, posaconazole, fluconazole, or voriconazole.
Beschreibung

Antifungal Agents | Itraconazole Systemic | Ketoconazole | posaconazole | Fluconazole | voriconazole

Datentyp

boolean

Alias
UMLS CUI [1]
C0003308
UMLS CUI [2,1]
C0064113
UMLS CUI [2,2]
C0205373
UMLS CUI [3]
C0022625
UMLS CUI [4]
C0936148
UMLS CUI [5]
C0016277
UMLS CUI [6]
C0393080
antimycobacterials- rifampin, rifabutin or rifapentine.
Beschreibung

Antimycobacterial agent | Rifampin | Rifabutin | rifapentine

Datentyp

boolean

Alias
UMLS CUI [1]
C0360390
UMLS CUI [2]
C0035608
UMLS CUI [3]
C0140575
UMLS CUI [4]
C0073372
corticosteroids- systemic dexamethasone.
Beschreibung

Adrenal Cortex Hormones | Dexamethasone Systemic

Datentyp

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2,1]
C0011777
UMLS CUI [2,2]
C0205373
propulsives- cisapride.
Beschreibung

PROPULSIVES | Cisapride

Datentyp

boolean

Alias
UMLS CUI [1]
C3653283
UMLS CUI [2]
C0072916
herbals- milk thistle or st. john's wart.
Beschreibung

Herbal Drugs | Milk thistle extract | Hypericum perforatum

Datentyp

boolean

Alias
UMLS CUI [1]
C1360419
UMLS CUI [2]
C0937640
UMLS CUI [3]
C0936242
6. patients that have been exposed to direct acting anti-viral agents
Beschreibung

Exposure to DIRECT ACTING ANTIVIRALS

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C3653501
7. patients with severe renal impairment (estimated glomerular filtration rate (egfr) <50 ml/min/1.73m2) or with end stage renal disease (esrd).
Beschreibung

Renal Insufficiency | Estimated Glomerular Filtration Rate | Kidney Failure, Chronic

Datentyp

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C3811844
UMLS CUI [3]
C0022661
8. patients with platelet count <50 x109/l, hemoglobin <10 g/dl, or neutrophils <0.5 x109/l.
Beschreibung

Platelet Count measurement | Hemoglobin measurement | Neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0200633
9. women who are pregnant.
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
10. men whose partners are pregnant or plan on becoming pregnant.
Beschreibung

Gender Partner Pregnancy | Gender Partner Planned Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0682323
UMLS CUI [1,3]
C0032961
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0682323
UMLS CUI [2,3]
C0032992
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hepatitis C NCT02214420

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Liver Cirrhosis
Item
1. targeted at least 20% enrollment of patients with cirrhosis
boolean
C0023890 (UMLS CUI [1])
Adult | Age
Item
2. adults >/= age 18 years.
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Hepatitis C Genotype
Item
3. active infection with hcv genotype 1
boolean
C0019196 (UMLS CUI [1,1])
C1285573 (UMLS CUI [1,2])
Health Insurance | sofosbuvir | Ribavirin
Item
4. must have health insurance that covers therapy with sof+rbv
boolean
C0021682 (UMLS CUI [1])
C2976303 (UMLS CUI [2])
C0035525 (UMLS CUI [3])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods Quantity | Childbearing Potential Pregnancy Tests
Item
5. female patients of childbearing age must have a negative pregnancy test prior to initiating therapy, use at least two effective methods of contraception during treatment, and undergo monthly pregnancy tests.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C3831118 (UMLS CUI [3,1])
C0032976 (UMLS CUI [3,2])
Patients Ineligible Interferon | Etiology Mental disorders | Etiology Autoimmune Diseases | Etiology Nervous system disorder
Item
6. patients must be either ifn-ineligible due to psychiatric, autoimmune, neurological, or other causes that are confirmed appropriate by the pi; or,
boolean
C0030705 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C3652465 (UMLS CUI [1,3])
C0015127 (UMLS CUI [2,1])
C0004936 (UMLS CUI [2,2])
C0015127 (UMLS CUI [3,1])
C0004364 (UMLS CUI [3,2])
C0015127 (UMLS CUI [4,1])
C0027765 (UMLS CUI [4,2])
Intolerance to Interferon | Etiology Influenza-like symptoms | Etiology Psychiatric problem | Etiology Cytopenia
Item
7. ifn-intolerant due to flu-like symptoms, psychiatric problems, cytopenia or other causes deemed appropriate by the pi.
boolean
C1744706 (UMLS CUI [1,1])
C3652465 (UMLS CUI [1,2])
C0015127 (UMLS CUI [2,1])
C0392171 (UMLS CUI [2,2])
C0015127 (UMLS CUI [3,1])
C1306597 (UMLS CUI [3,2])
C0015127 (UMLS CUI [4,1])
C0010828 (UMLS CUI [4,2])
Item Group
C0680251 (UMLS CUI)
HIV coinfection
Item
1. presence of hiv co-infection
boolean
C4062778 (UMLS CUI [1])
Liver carcinoma
Item
2. presence of hcc
boolean
C2239176 (UMLS CUI [1])
Organ Transplantation
Item
3. prior organ transplantation
boolean
C0029216 (UMLS CUI [1])
Hepatic decompensation
Item
4. any history of hepatic decompensation
boolean
C1394798 (UMLS CUI [1])
Intake Pharmaceutical Preparations
Item
5. patients taking any of the following medications:
boolean
C1512806 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Anticonvulsants | Carbamazepine | oxcarbazepine | Phenobarbital | Phenytoin
Item
anticonvulsants- carbamazepine, oxcarbazepine, phenobarbital, or phenytoin.
boolean
C0003286 (UMLS CUI [1])
C0006949 (UMLS CUI [2])
C0069751 (UMLS CUI [3])
C0031412 (UMLS CUI [4])
C0031507 (UMLS CUI [5])
Anti-Infective Agents | Erythromycin | Clarithromycin | telithromycin
Item
anti-infectives-erythromycin, clarithromycin, or telithromycin.
boolean
C0003204 (UMLS CUI [1])
C0014806 (UMLS CUI [2])
C0055856 (UMLS CUI [3])
C0907410 (UMLS CUI [4])
Antifungal Agents | Itraconazole Systemic | Ketoconazole | posaconazole | Fluconazole | voriconazole
Item
antifungals- systemic itraconazole, ketoconazole, posaconazole, fluconazole, or voriconazole.
boolean
C0003308 (UMLS CUI [1])
C0064113 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0022625 (UMLS CUI [3])
C0936148 (UMLS CUI [4])
C0016277 (UMLS CUI [5])
C0393080 (UMLS CUI [6])
Antimycobacterial agent | Rifampin | Rifabutin | rifapentine
Item
antimycobacterials- rifampin, rifabutin or rifapentine.
boolean
C0360390 (UMLS CUI [1])
C0035608 (UMLS CUI [2])
C0140575 (UMLS CUI [3])
C0073372 (UMLS CUI [4])
Adrenal Cortex Hormones | Dexamethasone Systemic
Item
corticosteroids- systemic dexamethasone.
boolean
C0001617 (UMLS CUI [1])
C0011777 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
PROPULSIVES | Cisapride
Item
propulsives- cisapride.
boolean
C3653283 (UMLS CUI [1])
C0072916 (UMLS CUI [2])
Herbal Drugs | Milk thistle extract | Hypericum perforatum
Item
herbals- milk thistle or st. john's wart.
boolean
C1360419 (UMLS CUI [1])
C0937640 (UMLS CUI [2])
C0936242 (UMLS CUI [3])
Exposure to DIRECT ACTING ANTIVIRALS
Item
6. patients that have been exposed to direct acting anti-viral agents
boolean
C0332157 (UMLS CUI [1,1])
C3653501 (UMLS CUI [1,2])
Renal Insufficiency | Estimated Glomerular Filtration Rate | Kidney Failure, Chronic
Item
7. patients with severe renal impairment (estimated glomerular filtration rate (egfr) <50 ml/min/1.73m2) or with end stage renal disease (esrd).
boolean
C1565489 (UMLS CUI [1])
C3811844 (UMLS CUI [2])
C0022661 (UMLS CUI [3])
Platelet Count measurement | Hemoglobin measurement | Neutrophil count
Item
8. patients with platelet count <50 x109/l, hemoglobin <10 g/dl, or neutrophils <0.5 x109/l.
boolean
C0032181 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0200633 (UMLS CUI [3])
Pregnancy
Item
9. women who are pregnant.
boolean
C0032961 (UMLS CUI [1])
Gender Partner Pregnancy | Gender Partner Planned Pregnancy
Item
10. men whose partners are pregnant or plan on becoming pregnant.
boolean
C0079399 (UMLS CUI [1,1])
C0682323 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2,1])
C0682323 (UMLS CUI [2,2])
C0032992 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video